Next Generation News and Research

RSS

Baxter to develop recombinant Factor IX proteins to treat hemophilia B

Baxter International Inc. has announced that it has initiated pre-clinical programs to develop recombinant Factor IX proteins to treat hemophilia B.

From Baxter International Inc. 7 Jan 2008

Sanofi Pasteur enters agreement eith Crucell for next-generation biologicals against rabies

Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that it has signed an exclusive collaboration and commercialization agreement with Crucell N.V. for Crucell's rabies monoclonal antibodies (MAbs), next-generation rabies biologicals to be used in association with rabies vaccine for post-exposure prophylaxis against this fatal disease.

4 Jan 2008

Researchers seek to make cavity-causing bacteria self-destruct

Bacteria that eat sugar and release cavity-causing acid onto teeth may soon be made dramatically more vulnerable to their own acid.

3 Jan 2008

FDA approves Hi-Flex mobile bearing knee prostheses

Mitchell Sheinkop, M.D., will be the first in the U.S. to surgically implant the just-approved Nex Gen LPS-Flex mobile bearing knee on February 20, 2008 at the Neurologic and Orthopedic Hospital of Chicago.

3 Jan 2008

Research could turn the tables on superbugs

Scientists in Australia and America believe they have found a way to deal with the increasing antibiotic resistance of deadly superbugs such as MRSA.

27 Dec 2007

Cancer research giants to present the CTRC-AACR San Antonio Breast Cancer Symposium

The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio and the American Association for Cancer Research (AACR) has announced a collaboration for the future of the San Antonio Breast Cancer Symposium (SABCS).

14 Dec 2007

Short pulses of low-energy laser light create better medical images

Detection and treatment of tumours, diseased blood vessels and other soft-tissue conditions could be significantly improved, thanks to an innovative imaging system being developed that uses both light and sound.

13 Dec 2007

Scientists strike blow in super bugs struggle

Scientists from the University of Manchester have pioneered new ways of tweaking the molecular structure of antibiotics - an innovation that could be crucial in the fight against powerful super bugs.

From The University of Manchester 5 Dec 2007

Wireless nano device for cell biology

A wireless, nano-scale voltmeter developed at the University of Michigan is overturning conventional wisdom about the physical environment inside cells.

3 Dec 2007

Bacteria cheat on their mates for own good

Pursuing our own short term interests by cheating on the rest of the population is not the preserve of the human race.

29 Nov 2007

Transcranial magnetic stimulation effective in treating major depression

Researchers at the University of Pennsylvania School of Medicine and other study sites have found that transcranial magnetic stimulation (TMS) – a non-invasive technique that excites neurons in the brain via magnetic pulses passed through the scalp – is a safe and effective, non-drug treatment with minimal side effects for patients with major depression who have tried other treatment options without benefit.

27 Nov 2007

Super-tiny structures for biomedical research

The University of Massachusetts Amherst is host to a new nanomedicine institute focused on developing super-tiny structures for biomedical research.

19 Nov 2007

Poxvirus' ability to hide from the immune system may aid vaccine design

The cowpox virus, a much milder cousin of the deadly smallpox virus, can keep infected host cells from warning the immune system that they have been compromised, researchers at Washington University School of Medicine in St. Louis have found.

16 Nov 2007

Pfizer and Nektar resolve outstanding Exubera contractual issues

Pfizer and Nektar Therapeutics have announced that the two companies have resolved all outstanding contractual issues in connection with Exubera and Nektar's innovative Next Generation Inhaled Insulin (NGI) product currently in Phase 1 clinical development.

14 Nov 2007

Hopkins report: Next generation contraceptive implants are cheaper, highly effective, and available now

The next generation of contraceptive implants offer an extremely effective way to expand family planning choices for women and reduce the incidence of maternal mortality worldwide, according to the latest issue of Population Reports, from the Johns Hopkins Bloomberg School of Public Health.

29 Oct 2007

Field mammalogy declining under financial pressures

Field research has traditionally been a fundamental training element for Mammalogists; however social, institutional and bureaucratic changes that have accelerated over the past decade are threatening the ability of Mammalogists to conduct fieldwork and train the next generation.

24 Oct 2007

GenVec receives extra funding for adenovector-based HIV vaccines program

GenVec, Inc. has announced that the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has executed its sixth option period (year seven) under its multi-year collaboration with GenVec to develop and manufacture novel adenovector-based HIV vaccines.

22 Oct 2007

Transgenics sped up

A new method of constructing artificial plant chromosomes from small rings of naturally occurring plant DNA can be used to transport multiple genes at once into embryonic plants where they are expressed, duplicated as plant cells divide, and passed on to the next generation -- a long-term goal for those interested in improving agricultural productivity.

19 Oct 2007

Massive reanalysis of genome data solves case of the lethal genes

It is better to be looked over than overlooked, Mae West supposedly said. These are words of wisdom for genome data-miners of today.

19 Oct 2007

Lilly and MacroGenics to develop and commercialize teplizumab

Eli Lilly and Company and MacroGenics, Inc. have announced that the two companies have entered into a global strategic alliance to develop and commercialize teplizumab, a humanized anti-CD3 monoclonal antibody, as well as other potential next generation anti-CD3 molecules for use in the treatment of autoimmune diseases.

19 Oct 2007